Member Info for OAPK20

Looks like ODX will manufacturing a fair chunk of the tests for the Consortium, sharing production of the tests with Abingdon Health England.

BBI Solutions supplying reagents and CIGA ltd distributing the tests.

BBI Solutions supply Corona Virus reagents - BBI Solutions has partnered with The Native Antigen Company to provide secure supply of SARS-CoV-2, COVID-19 antigens.
CIGA ltd - largest supplier of OTC self health tests - Customers include the NHS, Boots, ASDA, Tesco Sainsburys and most pharmacies.

He must have forgotten to top up !!

Yep if only ODX had links to China and Africa. No wait...

Press coverage. Front page not good? You think Sky, Beeb, ITV Ch4, US news won’t be all over this?

Your right depends on who produces the most. But a fag packet calculation evenly split

£125,000,000 each less what Mologic Ltd get.

Again - What is £10 x 50million divided by 4

The new immunity tests, expected to cost £10, have been devised by scientists at Oxford, working for the Government-backed Rapid Testing Consortium

Again - What is £10 x 50million divided by 4

The new immunity tests, expected to cost £10, have been devised by scientists at Oxford, working for the Government-backed Rapid Testing Consortium.

What’s £10 x 50million divided by 4?

Order made give up. You missed the boat

Go to Sunday mail website

£10 a test

Sunday Mail
Scientists hail game-changing immunity test: Government orders 50MILLION antibody testing kits that work in 20 minutes and could be ready by June as Boris Johnson returns to work on Monday

The consortium aims to harness the mass-production techniques of the diagnostic companies Abingdon Health in England, BBI Solutions in Wales, Omega Diagnostics in Scotland and CIGA Healthcare in Northern Ireland, which have the combined capacity to produce up to 50 million immunity tests every year. But with Mr Han**** struggling to hit his own target for testing people who fear they have the virus, the consortium is likely to face scepticism about its ability to produce the hoped-for million tests a week by the summer

Anyone know the name of the charity and who runs it?

How big? :-) China big?

Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing, announces that the National Medical Products Administration ("NMPA"), formerly the China Food and Drug Administration, has approved the Company's Food Detective(R) test for laboratory use in China .

Africa big?

Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing notes the publication on 3 April 2020 of the two phased diagnostic accuracy and feasibility-of-use evaluation study, conducted in Médecins Sans Frontiéres (MSF) supported health facilities in Malawi, Zimbabwe and the Democratic Republic of Congo.

Omega (AIM: ODX), the medical diagnostics company focused on CD4, food intolerance and allergy testing, announces that the Company has received approval from the Federal Ministry of Health ("MOH") to enable the VISITECT(R) CD4 350 test to be deployed in Nigeria.

Been on their Website since 1100

Bedfordshire, UK, 24 APRIL 2020: Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, disclosed today that work is well underway on a new diagnostic manufacturing facility adjacent to the firm’s current laboratory in Bedfordshire, UK.

The facility has been incorporated as an independent, sustainable social enterprise under the name of Global Access Diagnostics, with a commitment to deliver diagnostics at a fair price to both national and international markets.

The expansion is supported by the Foundation for Innovative New Diagnostics (FIND), a global non-profit dedicated to diagnostics for global health. It follows Mologic’s development of consistently high quality, independently verified diagnostic products, including ELISA laboratory tests and rapid diagnostic tests for diseases such as COVID-19 and Ebola.

The first products to be manufactured in the facility will be rapid diagnostic tests for COVID-19, as part of Mologic’s commitment to support the global pandemic response.

The new facility will be operational within eight weeks, enabling the company to produce up to 40 million tests per year, scaling from the existing manufacturing capability.

Current activities on setrusumab for the potential treatment of OI are focussed on preparations for the Phase 3 pediatric trial, which the Company is intending to start in 2H 2020.

Pumpers arrived then.

The BBC are promoting Oxbridge efforts. The tests Oxford Uni and Nuffield are evaluating are ones they are developing. The test OXB will be manufacturing is currently being assessed by PHE and NHS Scotland. It has already been independently validated. Just not by Oxford Uni.

BBC should cover all efforts including Mologic Ltd test.

Could be interesting.

Saudi Aramco has started to scale back production from its maximum capacity of around 12 million barrels per day in preparation for lowering its output to 8.5 million b/d in May

ODX. To much rum!

Also Oxford Uni tests - They are not 98% like OFX.

“ The research estimates the sensitivity of LFIA devices ranged from 55-70% versus RT-PCR test which diagnoses Covid-19, and 65-85% versus ELISA, with specificity 95-100% and 93-100% respectively.”

Test not rest

And what does the Oxford Uni rest have to do with ODX - Here’s what they actually think.

The investigations were led by the National Covid Testing Scientific Advisory Panel.

Professor Derrick Crook, of the Nuffield Department of Medicine and NIHR Oxford Biomedical Research Centre, University of Oxford, is the corresponding author of the study that has not been peer-reviewed.

The researchers write: “The performance of current LFIA devices is inadequate for most individual patient applications.

What like SNG holders not catching on that every time they mention a vaccine on telly box they’re talking about OXB vaccine?